{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T19:01:38Z","timestamp":1790276498098,"version":"4.1.0"},"reference-count":106,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2018,12,1]],"date-time":"2018-12-01T00:00:00Z","timestamp":1543622400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,12,1]],"date-time":"2018-12-01T00:00:00Z","timestamp":1543622400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2018,12,5]],"date-time":"2018-12-05T00:00:00Z","timestamp":1543968000000},"content-version":"vor","delay-in-days":4,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81070687"],"award-info":[{"award-number":["81070687"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81170805"],"award-info":[{"award-number":["81170805"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81670714"],"award-info":[{"award-number":["81670714"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004826","name":"Beijing Natural Science Foundation","doi-asserted-by":"publisher","award":["7121012"],"award-info":[{"award-number":["7121012"]}],"id":[{"id":"10.13039\/501100004826","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Collaborative innovation team project of medical and health science and technology innovation project of Chinese Academy of Medical Sciences","award":["2016-I2M-3-003"],"award-info":[{"award-number":["2016-I2M-3-003"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Osteoporosis and Sarcopenia"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1016\/j.afos.2018.12.001","type":"journal-article","created":{"date-parts":[[2018,12,12]],"date-time":"2018-12-12T13:44:48Z","timestamp":1544622288000},"page":"119-127","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":60,"title":["Tumor-induced osteomalacia"],"prefix":"10.1016","volume":"4","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1920-3425","authenticated-orcid":false,"given":"Zinan","family":"Yin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0271-1709","authenticated-orcid":false,"given":"Juan","family":"Du","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5526-6736","authenticated-orcid":false,"given":"Fan","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7768-5536","authenticated-orcid":false,"given":"Weibo","family":"Xia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.afos.2018.12.001_bib1","first-page":"33","article-title":"Osteomalacia with Looser's nodes (Milkman's syndrome) due to a raised resistance to vitamin D acquired about the age of 15 years","volume":"16","author":"McCance","year":"1947","journal-title":"Q\u00a0J Med"},{"key":"10.1016\/j.afos.2018.12.001_bib2","first-page":"554","article-title":"Rickets following bone tumor","volume":"14","author":"Prader","year":"1959","journal-title":"Helv Paediatr Acta"},{"key":"10.1016\/j.afos.2018.12.001_bib3","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1507\/endocrj.EJ16-0587","article-title":"The diagnostic dilemma of tumor induced osteomalacia: a retrospective analysis of 144 cases","volume":"64","author":"Feng","year":"2017","journal-title":"Endocr J"},{"key":"10.1016\/j.afos.2018.12.001_bib4","doi-asserted-by":"crossref","first-page":"3618","DOI":"10.1007\/s11999-013-3178-1","article-title":"The phosphaturic mesenchymal tumor: why is definitive diagnosis and curative surgery often delayed?","volume":"471","author":"Ledford","year":"2013","journal-title":"Clin Orthop Relat Res"},{"key":"10.1016\/j.afos.2018.12.001_bib5","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/00000478-200401000-00001","article-title":"Most osteomalacia-associated mesenchymal tumors are a single histopathologic entity: an analysis of 32 cases and a comprehensive review of the literature","volume":"28","author":"Folpe","year":"2004","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.afos.2018.12.001_bib6","doi-asserted-by":"crossref","first-page":"1967","DOI":"10.1002\/jbmr.1642","article-title":"Tumor-induced osteomalacia: an important cause of adult-onset hypophosphatemic osteomalacia in China: report of 39 cases and review of the literature","volume":"27","author":"Jiang","year":"2012","journal-title":"J\u00a0Bone Miner Res"},{"key":"10.1016\/j.afos.2018.12.001_bib7","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1186\/s12891-015-0496-3","article-title":"Surgical treatment of tumor-induced osteomalacia: a retrospective review of 40 cases with extremity tumors","volume":"16","author":"Sun","year":"2015","journal-title":"BMC Musculoskelet Disord"},{"key":"10.1016\/j.afos.2018.12.001_bib8","doi-asserted-by":"crossref","first-page":"177","DOI":"10.4158\/EP10151.OR","article-title":"Tumor-induced osteomalacia: a single center experience","volume":"17","author":"Jagtap","year":"2011","journal-title":"Endocr Pract"},{"key":"10.1016\/j.afos.2018.12.001_bib9","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1507\/endocrj.EJ15-0275","article-title":"Nationwide survey of fibroblast growth factor 23 (FGF23)-related hypophosphatemic diseases in Japan: prevalence, biochemical data and treatment","volume":"62","author":"Endo","year":"2015","journal-title":"Endocr J"},{"key":"10.1016\/j.afos.2018.12.001_bib10","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1111\/1346-8138.12602","article-title":"Phosphaturic mesenchymal tumor, mixed connective tissue type, non-phosphaturic variant: report of a case and review of 32 cases from the Japanese published work","volume":"41","author":"Honda","year":"2014","journal-title":"J\u00a0Dermatol"},{"key":"10.1016\/j.afos.2018.12.001_bib11","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1097\/BPB.0b013e32832f59cb","article-title":"A\u00a09-month-old phosphaturic mesenchymal tumor mimicking the intractable rickets","volume":"19","author":"Jung","year":"2010","journal-title":"J\u00a0Pediatr Orthop B"},{"key":"10.1016\/j.afos.2018.12.001_bib12","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1007\/s00774-016-0756-9","article-title":"Reports of 17 Chinese patients with tumor-induced osteomalacia","volume":"35","author":"Yu","year":"2017","journal-title":"J\u00a0Bone Miner Metab"},{"key":"10.1016\/j.afos.2018.12.001_bib13","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.anl.2017.05.006","article-title":"Phosphaturic mesenchymal tumor of the nasal cavity and paranasal sinuses: a clinical curiosity presenting a diagnostic challenge","volume":"45","author":"Kane","year":"2018","journal-title":"Auris Nasus Larynx"},{"key":"10.1016\/j.afos.2018.12.001_bib14","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/1758-3284-3-16","article-title":"Phosphaturic mesenchymal tumor of the sinonasal area: case report and review of the literature","volume":"3","author":"Kom\u00ednek","year":"2011","journal-title":"Head Neck Oncol"},{"key":"10.1016\/j.afos.2018.12.001_bib15","doi-asserted-by":"crossref","first-page":"2345","DOI":"10.1007\/s00198-016-3543-5","article-title":"Stability and degradation of fibroblast growth factor 23 (FGF23): the effect of time and temperature and assay type","volume":"27","author":"El-Maouche","year":"2016","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.afos.2018.12.001_bib16","doi-asserted-by":"crossref","first-page":"4957","DOI":"10.1210\/jc.2002-021105","article-title":"Increased circulatory level of biologically active full-length FGF-23 in patients with hypophosphatemic rickets\/osteomalacia","volume":"87","author":"Yamazaki","year":"2002","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.afos.2018.12.001_bib17","doi-asserted-by":"crossref","first-page":"2055","DOI":"10.1210\/jc.2005-2105","article-title":"Sensitivity of fibroblast growth factor 23 measurements in tumor-induced osteomalacia","volume":"91","author":"Imel","year":"2006","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.afos.2018.12.001_bib18","doi-asserted-by":"crossref","first-page":"3541","DOI":"10.1210\/jc.2011-1239","article-title":"Iron modifies plasma FGF23 differently in autosomal dominant hypophosphatemic rickets and healthy humans","volume":"96","author":"Imel","year":"2011","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.afos.2018.12.001_bib19","doi-asserted-by":"crossref","first-page":"1971","DOI":"10.1515\/cclm-2013-0208","article-title":"Method-specific differences in plasma fibroblast growth factor 23 measurement using four commercial ELISAs","volume":"51","author":"Smith","year":"2013","journal-title":"Clin Chem Lab Med"},{"key":"10.1016\/j.afos.2018.12.001_bib20","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1073\/pnas.0902006107","article-title":"Isolated C-terminal tail of FGF23 alleviates hypophosphatemia by inhibiting FGF23-FGFR-Klotho complex formation","volume":"107","author":"Goetz","year":"2010","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.afos.2018.12.001_bib21","first-page":"1158","article-title":"Levels and dynamic changes of serum fibroblast growth factor 23 in hypophosphatemic rickets\/osteomalacia","volume":"123","author":"Xia","year":"2010","journal-title":"Chin Med J (Engl)"},{"key":"10.1016\/j.afos.2018.12.001_bib22","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1016\/j.bone.2008.02.014","article-title":"Clinical usefulness of measurement of fibroblast growth factor 23 (FGF23) in hypophosphatemic patients: proposal of diagnostic criteria using FGF23 measurement","volume":"42","author":"Endo","year":"2008","journal-title":"Bone"},{"key":"10.1016\/j.afos.2018.12.001_bib23","doi-asserted-by":"crossref","first-page":"2374","DOI":"10.1210\/jc.2006-2865","article-title":"Determination of the elimination half-life of fibroblast growth factor-23","volume":"92","author":"Khosravi","year":"2007","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.afos.2018.12.001_bib24","doi-asserted-by":"crossref","first-page":"3979","DOI":"10.1210\/jc.2004-0406","article-title":"Venous sampling for fibroblast growth factor-23 confirms preoperative diagnosis of tumor-induced osteomalacia","volume":"89","author":"Takeuchi","year":"2004","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"Suppl 4","key":"10.1016\/j.afos.2018.12.001_bib25","doi-asserted-by":"crossref","first-page":"iv45","DOI":"10.1093\/ndt\/gfu217","article-title":"Genetic diseases of renal phosphate handling","volume":"29","author":"Wagner","year":"2014","journal-title":"Nephrol Dial Transplant"},{"issue":"3","key":"10.1016\/j.afos.2018.12.001_bib26","article-title":"Tumor-induced osteomalacia","volume":"7","author":"Kumar","year":"2015","journal-title":"Transl Endocrinol Metab"},{"key":"10.1016\/j.afos.2018.12.001_bib27","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/S0140-6736(72)92844-9","article-title":"Distinctive tumors of bone and soft tissue causing acquired vitamin-D-resistant osteomalacia","volume":"1","author":"Evans","year":"1972","journal-title":"Lancet"},{"key":"10.1016\/j.afos.2018.12.001_bib28","doi-asserted-by":"crossref","first-page":"1442","DOI":"10.1002\/1097-0142(19870415)59:8<1442::AID-CNCR2820590810>3.0.CO;2-Q","article-title":"Phosphaturic mesenchymal tumors. A polymorphous group causing osteomalacia or rickets","volume":"59","author":"Weidner","year":"1987","journal-title":"Cancer"},{"key":"10.1016\/j.afos.2018.12.001_bib29","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1097\/PAS.0000000000000890","article-title":"Phosphaturic mesenchymal tumors: clinicopathologic, immunohistochemical and molecular analysis of 22 cases expanding their morphologic and Immunophenotypic spectrum","volume":"41","author":"Agaimy","year":"2017","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.afos.2018.12.001_bib30","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1210\/jc.2013-3791","article-title":"Tumor(s) induced osteomalacia-a curious case of double trouble","volume":"99","author":"Sahoo","year":"2014","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.afos.2018.12.001_bib31","doi-asserted-by":"crossref","first-page":"1825","DOI":"10.1007\/s00256-015-2246-x","article-title":"Locally aggressive and multifocal phosphaturic mesenchymal tumors: two unusual cases of tumor-induced osteomalacia","volume":"44","author":"Higley","year":"2015","journal-title":"Skeletal Radiol"},{"key":"10.1016\/j.afos.2018.12.001_bib32","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1210\/jc.2015-3854","article-title":"Needle(s) in the haystack-synchronous multifocal tumor-induced osteomalacia","volume":"10","author":"Annamalai","year":"2016","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.afos.2018.12.001_bib33","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1186\/s12891-017-1446-z","article-title":"A\u00a0rare case of multiple phosphaturic mesenchymal tumors along a tendon sheath inducing osteomalacia","volume":"18","author":"Arai","year":"2017","journal-title":"BMC Musculoskelet Disord"},{"key":"10.1016\/j.afos.2018.12.001_bib34","doi-asserted-by":"crossref","first-page":"2711","DOI":"10.1016\/j.humpath.2013.07.016","article-title":"Phosphaturic mesenchymal tumors show positive staining for somatostatin receptor 2A (SSTR2A)","volume":"44","author":"Houang","year":"2013","journal-title":"Hum Pathol"},{"key":"10.1016\/j.afos.2018.12.001_bib35","first-page":"1922","article-title":"Somatostatin and vasoactive intestinal peptide receptors in human mesenchymal tumors: in\u00a0vitro identification","volume":"56","author":"Reubi","year":"1996","journal-title":"Cancer Res"},{"key":"10.1016\/j.afos.2018.12.001_bib36","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1097\/PAS.0000000000000290","article-title":"A\u00a0novel chromogenic in situ hybridization assay for FGF23 mRNA in phosphaturic mesenchymal tumors","volume":"39","author":"Carter","year":"2015","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.afos.2018.12.001_bib37","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1111\/his.13377","article-title":"Histopathological and genetic review of phosphaturic mesenchymal tumors, mixed connective tissue variant","volume":"72","author":"Yamada","year":"2018","journal-title":"Histopathology"},{"key":"10.1016\/j.afos.2018.12.001_bib38","doi-asserted-by":"crossref","first-page":"6500","DOI":"10.1073\/pnas.101545198","article-title":"Cloning and characterization of FGF23 as a causative factor of tumor-induced osteomalacia","volume":"98","author":"Shimada","year":"2001","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.afos.2018.12.001_bib39","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1006\/bbrc.2001.5084","article-title":"FGF-23 inhibits renal tubular phosphate transport and is a PHEX substrate","volume":"284","author":"Bowe","year":"2001","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.afos.2018.12.001_bib40","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1359\/JBMR.0301264","article-title":"FGF-23 is a potent regulator of vitamin D metabolism and phosphate homeostasis","volume":"19","author":"Shimada","year":"2004","journal-title":"J\u00a0Bone Miner Res"},{"key":"10.1016\/j.afos.2018.12.001_bib41","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1172\/JCI200419081","article-title":"Targeted ablation of Fgf23 demonstrates an essential physiological role of FGF23 in phosphate and vitamin D metabolism","volume":"113","author":"Shimada","year":"2004","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.afos.2018.12.001_bib42","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1136\/jclinpath-2012-200852","article-title":"Frequent expression of fibroblast growth factor-23 (FGF23) mRNA in aneurysmal bone cysts and chondromyxoid fibromas","volume":"65","author":"Graham","year":"2012","journal-title":"J\u00a0Clin Pathol"},{"key":"10.1016\/j.afos.2018.12.001_bib43","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1097\/PAS.0b013e3181aa2311","article-title":"RT-PCR analysis for FGF23 using paraffin sections in the diagnosis of phosphaturic mesenchymal tumors with and without known tumor induced osteomalacia","volume":"33","author":"Bahrami","year":"2009","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.afos.2018.12.001_bib44","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/s13000-016-0477-3","article-title":"Immunohistochemical and molecular detection of the expression of FGF23 in phosphaturic mesenchymal tumors including the non-phosphaturic variant","volume":"11","author":"Shiba","year":"2016","journal-title":"Diagn Pathol"},{"key":"10.1016\/j.afos.2018.12.001_bib45","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1006\/geno.2000.6235","article-title":"MEPE, a new gene expressed in bone marrow and tumors causing osteomalacia","volume":"67","author":"Rowe","year":"2000","journal-title":"Genomics"},{"key":"10.1016\/j.afos.2018.12.001_bib46","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1038\/modpathol.3800084","article-title":"Expression of dentin matrix protein 1 in tumors causing oncogenic osteomalacia","volume":"17","author":"Toyosawa","year":"2004","journal-title":"Mod Pathol"},{"key":"10.1016\/j.afos.2018.12.001_bib47","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1359\/jbmr.2002.17.6.1102","article-title":"Tumors associated with oncogenic osteomalacia express genes important in bone and mineral metabolism","volume":"17","author":"De Beur","year":"2002","journal-title":"J\u00a0Bone Miner Res"},{"key":"10.1016\/j.afos.2018.12.001_bib48","first-page":"9422","article-title":"Fibroblast growth factor receptor 1 (FGFR1) expression in phosphaturic mesenchymal tumors","volume":"8","author":"Tajima","year":"2015","journal-title":"Int J Clin Exp Pathol"},{"key":"10.1016\/j.afos.2018.12.001_bib49","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1007\/s40618-018-0849-5","article-title":"Phosphaturic mesenchymal tumors: what an endocrinologist should know","volume":"41","author":"Boland","year":"2018","journal-title":"J\u00a0Endocrinol Invest"},{"key":"10.1016\/j.afos.2018.12.001_bib50","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1093\/ckj\/sfu004","article-title":"Tumor-induced osteomalacia with normal systemic fibroblast growth factor-23 level","volume":"7","author":"Amblee","year":"2014","journal-title":"Clin Kidney J"},{"key":"10.1016\/j.afos.2018.12.001_bib51","doi-asserted-by":"crossref","first-page":"288","DOI":"10.2106\/00004623-198971020-00017","article-title":"Osteomalacia secondary to osteosarcoma. A case report","volume":"71","author":"Cheng","year":"1989","journal-title":"J\u00a0Bone Joint Surg Am"},{"key":"10.1016\/j.afos.2018.12.001_bib52","doi-asserted-by":"crossref","first-page":"90","DOI":"10.7861\/clinmedicine.14-1-90","article-title":"An aggressive bone tumor: osteogenic osteomalacia","volume":"14","author":"Postlethwaite","year":"2014","journal-title":"Clin Med (Lond)"},{"key":"10.1016\/j.afos.2018.12.001_bib53","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000006750","article-title":"Malignant phosphaturic mesenchymal tumor with pulmonary metastasis: a case report","volume":"96","author":"Qiu","year":"2017","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.afos.2018.12.001_bib54","series-title":"Distant lung metastases caused by a histologically benign phosphaturic mesenchymal tumor. Endocrinol Diabetes Metab Case Rep 2018 May 16","author":"Yavropoulou","year":"2018"},{"key":"10.1016\/j.afos.2018.12.001_bib55","doi-asserted-by":"crossref","first-page":"4403","DOI":"10.1210\/jc.2014-2120","article-title":"Ovarian cancer-related hypophosphatemic osteomalacia-a case report","volume":"99","author":"Lin","year":"2014","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.afos.2018.12.001_bib56","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1159\/000282746","article-title":"Prostate cancer-induced oncogenic hypophosphatemic osteomalacia","volume":"55","author":"Nakahama","year":"1995","journal-title":"Urol Int"},{"key":"10.1016\/j.afos.2018.12.001_bib57","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1210\/jc.2012-3473","article-title":"Oncogenic osteomalacia due to FGF23-expressing colon adenocarcinoma","volume":"98","author":"Leaf","year":"2013","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.afos.2018.12.001_bib58","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1177\/1066896915617828","article-title":"FGF23-associated tumor-induced osteomalacia in a patient with small cell carcinoma: a case report and regulatory mechanism study","volume":"24","author":"Sauder","year":"2016","journal-title":"Int J Surg Pathol"},{"key":"10.1016\/j.afos.2018.12.001_bib59","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/j.jsbmb.2006.11.010","article-title":"The phosphatonins and the regulation of phosphate transport and vitamin D metabolism","volume":"103","author":"Sommer","year":"2007","journal-title":"J\u00a0Steroid Biochem Mol Biol"},{"key":"10.1016\/j.afos.2018.12.001_bib60","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.amjms.2016.04.013","article-title":"Hypophosphatemia-induced cardiomyopathy","volume":"352","author":"Ariyoshi","year":"2016","journal-title":"Am J Med Sci"},{"key":"10.1016\/j.afos.2018.12.001_bib61","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1111\/j.1939-1676.1989.tb03091.x","article-title":"Hypophosphatemia. Causes and clinical consequences","volume":"3","author":"Forrester","year":"1989","journal-title":"J\u00a0Vet Intern Med"},{"key":"10.1016\/j.afos.2018.12.001_bib62","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1007\/s00467-012-2364-9","article-title":"Hypophosphatemia and growth","volume":"28","author":"Santos","year":"2013","journal-title":"Pediatr Nephrol"},{"key":"10.1016\/j.afos.2018.12.001_bib63","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1053\/j.ackd.2010.11.004","article-title":"Intestinal phosphate transport","volume":"18","author":"Sabbagh","year":"2011","journal-title":"Adv Chronic Kidney Dis"},{"key":"10.1016\/j.afos.2018.12.001_bib64","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1146\/annurev-physiol-030212-183748","article-title":"Phosphate transporters and their function","volume":"75","author":"Biber","year":"2013","journal-title":"Annu Rev Physiol"},{"key":"10.1016\/j.afos.2018.12.001_bib65","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1097\/MNH.0000000000000053","article-title":"Renal phosphate transporters","volume":"23","author":"Lederer","year":"2014","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"10.1016\/j.afos.2018.12.001_bib66","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1056\/NEJM199406093302304","article-title":"Brief report: inhibition of renal phosphate transport by a tumor product in a patient with oncogenic osteomalacia","volume":"330","author":"Cai","year":"1994","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.afos.2018.12.001_bib67","doi-asserted-by":"crossref","first-page":"1679","DOI":"10.1056\/NEJM199406093302310","article-title":"Tumor-induced osteomalacia-unveiling a new hormone","volume":"330","author":"Econs","year":"1994","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.afos.2018.12.001_bib68","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1523-1755.2004.00355.x","article-title":"The phosphatonin pathway: new insights in phosphate homeostasis","volume":"65","author":"Schiavi","year":"2004","journal-title":"Kidney Int"},{"key":"10.1016\/j.afos.2018.12.001_bib69","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1007\/s00467-008-0751-z","article-title":"Regulation of phosphate homeostasis by the phosphatonins and other novel mediators","volume":"23","author":"Shaikh","year":"2008","journal-title":"Pediatr Nephrol"},{"key":"10.1016\/j.afos.2018.12.001_bib70","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1038\/nature05315","article-title":"Klotho converts canonical FGF receptor into a specific receptor for FGF23","volume":"444","author":"Urakawa","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.afos.2018.12.001_bib71","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1002\/path.4465","article-title":"Identification of a novel FN1-FGFR1 genetic fusion as a frequent event in phosphaturic mesenchymal tumor","volume":"235","author":"Lee","year":"2015","journal-title":"J\u00a0Pathol"},{"key":"10.1016\/j.afos.2018.12.001_bib72","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1038\/modpathol.2016.137","article-title":"Characterization of FN1-FGFR1 and novel FN1-FGF1 fusion genes in a large series of phosphaturic mesenchymal tumors","volume":"29","author":"Lee","year":"2016","journal-title":"Mod Pathol"},{"key":"10.1016\/j.afos.2018.12.001_bib73","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1038\/nrd2792","article-title":"The FGF family: biology, pathophysiology and therapy","volume":"8","author":"Beenken","year":"2009","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.afos.2018.12.001_bib74","doi-asserted-by":"crossref","first-page":"15292","DOI":"10.1074\/jbc.271.25.15292","article-title":"Receptor specificity of the fibroblast growth factor family","volume":"271","author":"Ornitz","year":"1996","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.afos.2018.12.001_bib75","doi-asserted-by":"crossref","first-page":"16011","DOI":"10.1038\/boneres.2016.11","article-title":"The hypoxia-inducible factor-1\u03b1 activates ectopic production of fibroblast growth factor 23 in tumor-induced osteomalacia","volume":"4","author":"Zhang","year":"2016","journal-title":"Bone Res"},{"key":"10.1016\/j.afos.2018.12.001_bib76","doi-asserted-by":"crossref","first-page":"3599","DOI":"10.1210\/jc.2011-1757","article-title":"The importance of whole body imaging in tumor-induced osteomalacia","volume":"96","author":"Chong","year":"2011","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.afos.2018.12.001_bib77","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1097\/00003072-199902000-00016","article-title":"Indium-111 pentetreotide scintigraphy of mesenchymal tumor with oncogenic osteomalacia","volume":"24","author":"Nguyen","year":"1999","journal-title":"Clin Nucl Med"},{"key":"10.1016\/j.afos.2018.12.001_bib78","series-title":"Effective localization in tumor-induced osteomalacia using 68Ga-DOTATOC-PET\/CT, venous sampling and 3T-MRI. Endocrinol Diabetes Metab Case Rep 2017 Apr 19","author":"Kawai","year":"2017"},{"key":"10.1016\/j.afos.2018.12.001_bib79","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1016\/j.ijom.2018.02.008","article-title":"Maxillary tumor-induced osteomalacia","volume":"47","author":"Emodi","year":"2018","journal-title":"Int J Oral Maxillofac Surg"},{"key":"10.1016\/j.afos.2018.12.001_bib80","doi-asserted-by":"crossref","first-page":"3575","DOI":"10.1210\/jc.2016-2052","article-title":"68Ga-DOTATATE for tumor localization in tumor-induced osteomalacia","volume":"101","author":"El-Maouche","year":"2016","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.afos.2018.12.001_bib81","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.bone.2014.04.016","article-title":"68Ga DOTA-TATE PET\/CT allows tumor localization in patients with tumor-induced osteomalacia but negative 111In-octreotide SPECT\/CT","volume":"64","author":"Breer","year":"2014","journal-title":"Bone"},{"key":"10.1016\/j.afos.2018.12.001_bib82","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1007\/s002590050034","article-title":"Affinity profiles for human somatostatin receptor subtypes SST1-SST5 of somatostatin radiotracers selected for scintigraphic and radiotherapeutic use","volume":"27","author":"Reubi","year":"2000","journal-title":"Eur J Nucl Med"},{"key":"10.1016\/j.afos.2018.12.001_bib83","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1097\/RLU.0000000000000854","article-title":"68Ga DOTATATE PET\/CT is an accurate imaging modality in the detection of culprit tumors causing osteomalacia","volume":"40","author":"Zhang","year":"2015","journal-title":"Clin Nucl Med"},{"key":"10.1016\/j.afos.2018.12.001_bib84","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1002\/jbmr.1881","article-title":"Tumor localization and biochemical response to cure in tumor-induced osteomalacia","volume":"28","author":"Chong","year":"2013","journal-title":"J\u00a0Bone Miner Res"},{"key":"10.1016\/j.afos.2018.12.001_bib85","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1002\/jbmr.316","article-title":"Selective venous catheterization for the localization of phosphaturic mesenchymal tumors","volume":"26","author":"Andreopoulou","year":"2011","journal-title":"J\u00a0Bone Miner Res"},{"key":"10.1016\/j.afos.2018.12.001_bib86","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1530\/EJE-07-0779","article-title":"Tumor producing fibroblast growth factor 23 localized by two-staged venous sampling","volume":"158","author":"van Boekel","year":"2008","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.afos.2018.12.001_bib87","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.2106\/JBJS.N.01299","article-title":"Surgical treatments of tumor-induced osteomalacia lesions in long bones: seventeen cases with more than one year of follow-up","volume":"97","author":"Wang","year":"2015","journal-title":"J\u00a0Bone Joint Surg Am"},{"key":"10.1016\/j.afos.2018.12.001_bib88","doi-asserted-by":"crossref","first-page":"3049","DOI":"10.1210\/jc.2013-4515","article-title":"Radiofrequency ablation, an effective modality of treatment in tumor-induced osteomalacia: a case series of three patients","volume":"99","author":"Jadhav","year":"2014","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.afos.2018.12.001_bib89","doi-asserted-by":"crossref","first-page":"3421","DOI":"10.1210\/jc.2012-1719","article-title":"Successful treatment of tumor-induced osteomalacia with CT-guided percutaneous ethanol and cryoablation","volume":"97","author":"Tutton","year":"2012","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.afos.2018.12.001_bib90","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1016\/j.jbspin.2015.09.011","article-title":"Osteomalacia by a mesenchymal-FGF23-producing tumor: successful treatment with radiofrequency ablation. A case report","volume":"83","author":"Igney-Oertel","year":"2016","journal-title":"Joint Bone Spine"},{"key":"10.1016\/j.afos.2018.12.001_bib91","doi-asserted-by":"crossref","first-page":"2248","DOI":"10.1002\/jbmr.3219","article-title":"Multimodality image-guided cryoablation for inoperable tumor-induced osteomalacia","volume":"32","author":"Tella","year":"2017","journal-title":"J\u00a0Bone Miner Res"},{"key":"10.1016\/j.afos.2018.12.001_bib92","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1093\/rheumatology\/39.12.1415","article-title":"Four cases of acquired hypophosphataemic ('oncogenic') osteomalacia. Problems of diagnosis, treatment and long-term management","volume":"39","author":"Clunie","year":"2000","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.afos.2018.12.001_bib93","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1007\/978-1-4613-4217-5_44","article-title":"The action of 1alphahydroxy vitamin D3 and phosphate supplements in hypophosphataemic osteomalacia","volume":"81","author":"Peacock","year":"1977","journal-title":"Adv Exp Med Biol"},{"key":"10.1016\/j.afos.2018.12.001_bib94","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1590\/S0004-27302006000100021","article-title":"Hyperparathyroidism associated with hypophosphatemic osteomalacia: case report and review of the literature","volume":"50","author":"Moreira","year":"2006","journal-title":"Arq Bras Endocrinol Metabol"},{"key":"10.1016\/j.afos.2018.12.001_bib95","doi-asserted-by":"crossref","first-page":"375","DOI":"10.4158\/EP.7.5.375","article-title":"Tertiary hyperparathyroidism after high-dose phosphate therapy in adult-onset hypophosphatemic osteomalacia","volume":"7","author":"Younis","year":"2001","journal-title":"Endocr Pract"},{"key":"10.1016\/j.afos.2018.12.001_bib96","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1359\/jbmr.070304","article-title":"Cinacalcet in the management of tumor-induced osteomalacia","volume":"22","author":"Geller","year":"2007","journal-title":"J\u00a0Bone Miner Res"},{"key":"10.1016\/j.afos.2018.12.001_bib97","doi-asserted-by":"crossref","first-page":"1883","DOI":"10.1056\/NEJMoa010839","article-title":"Octreotide therapy for tumor-induced osteomalacia","volume":"345","author":"Seufert","year":"2001","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.afos.2018.12.001_bib98","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.1002\/jbmr.3162","article-title":"Octreotide is ineffective in treating tumor-induced osteomalacia: results of a short-term therapy","volume":"32","author":"Ovejero","year":"2017","journal-title":"J\u00a0Bone Miner Res"},{"key":"10.1016\/j.afos.2018.12.001_bib99","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1007\/s00223-010-9369-9","article-title":"The levels of somatostatin receptors in causative tumors of oncogenic osteomalacia are insufficient for their agonist to normalize serum phosphate levels","volume":"86","author":"Ishii","year":"2010","journal-title":"Calcif Tissue Int"},{"key":"10.1016\/j.afos.2018.12.001_bib100","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1210\/js.2016-1088","article-title":"Peptide receptor radionuclide and octreotide: a novel approach for metastatic tumor-induced osteomalacia","volume":"1","author":"Nair","year":"2017","journal-title":"J\u00a0Endocr Soc"},{"key":"10.1016\/j.afos.2018.12.001_bib101","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1007\/s00223-015-0029-y","article-title":"FGF23-FGF receptor\/Klotho pathway as a new drug target for disorders of bone and mineral metabolism","volume":"98","author":"Fukumoto","year":"2016","journal-title":"Calcif Tissue Int"},{"key":"10.1016\/j.afos.2018.12.001_bib102","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1172\/JCI72829","article-title":"Randomized trial of the anti-FGF23 antibody KRN23 in X-linked hypophosphatemia","volume":"124","author":"Carpenter","year":"2014","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.afos.2018.12.001_bib103","doi-asserted-by":"crossref","first-page":"2565","DOI":"10.1210\/jc.2015-1551","article-title":"Prolonged correction of serum phosphorus in adults with X-linked hypophosphatemia using monthly doses of KRN23","volume":"100","author":"Imel","year":"2015","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.afos.2018.12.001_bib104","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1002\/jbmr.3475","article-title":"A\u00a0randomized, double-blind, placebo-controlled, phase 3 trial evaluating the efficacy of burosumab, an anti-FGF23 antibody, in adults with X-linked hypophosphatemia: week 24 primary analysis","volume":"33","author":"Insogna","year":"2018","journal-title":"J\u00a0Bone Miner Res"},{"key":"10.1016\/j.afos.2018.12.001_bib105","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1002\/jbmr.1810","article-title":"Pharmacological inhibition of fibroblast growth factor (FGF) receptor signaling ameliorates FGF23-mediated hypophosphatemic rickets","volume":"28","author":"W\u00f6hrle","year":"2013","journal-title":"J\u00a0Bone Miner Res"},{"key":"10.1016\/j.afos.2018.12.001_bib106","doi-asserted-by":"crossref","first-page":"1883","DOI":"10.1002\/jbmr.401","article-title":"Fibroblast growth factor 23 regulates renal 1,25-dihydroxyvitamin D and phosphate metabolism via the MAP kinase signaling pathway in Hyp mice","volume":"26","author":"Ranch","year":"2011","journal-title":"J\u00a0Bone Miner Res"}],"container-title":["Osteoporosis and Sarcopenia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S240552551830092X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S240552551830092X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T07:34:19Z","timestamp":1762500859000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S240552551830092X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,12]]},"references-count":106,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["S240552551830092X"],"URL":"https:\/\/doi.org\/10.1016\/j.afos.2018.12.001","relation":{},"ISSN":["2405-5255"],"issn-type":[{"value":"2405-5255","type":"print"}],"subject":[],"published":{"date-parts":[[2018,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Tumor-induced osteomalacia","name":"articletitle","label":"Article Title"},{"value":"Osteoporosis and Sarcopenia","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.afos.2018.12.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 The Korean Society of Osteoporosis. Publishing services by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}